Loading...
Novobiocin analogues with second-generation noviose surrogates
Zhao, Huiping Blagg, Brian S. J.
Zhao, Huiping
Blagg, Brian S. J.
Citations
Altmetric:
Abstract
Hsp90 is a promising therapeutic target for the treatment of cancer. Novobiocin is the first Hsp90 C-terminal inhibitor ever identified and recent structure-activity relationship studies on the noviose sugar identified several commercially available amines as suitable surrogates. In an effort to further understand this region of the molecule, analogues containing various N′-amino substituents were prepared and evaluated against two breast cancer cell lines for determination of their efficacy. Compound 37j manifested the most potent anti-proliferative activity from these studies and induced Hsp90-dependent client protein degradation at mid nano-molar concentrations.
Description
Date
2013-01-15
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Collections
Archive Status
This item contains archived web content.
Files
Loading...
Zhao_Elsevier_2013.pdf
Adobe PDF, 329.77 KB
Research Projects
Organizational Units
Journal Issue
Keywords
Heat shock protein 90, Hsp90 inhibitors, Novobiocin analogues, Breast cancer
Citation
Zhao, H., & Blagg, B. S. J. (2013). Novobiocin analogues with second-generation noviose surrogates. Bioorganic & Medicinal Chemistry Letters, 23(2), 552–557. http://doi.org/10.1016/j.bmcl.2012.11.022